Addressing a potential health threat in a product millions of parents have given their children, the maker of the anti-diarrhea medicine Kaopectate agreed to slash its lead levels in a settlement with ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. The maker of ...

The makers of Kaopectate agreed Thursday to reformulate all of its popular antidiarrhea products so they no longer contain potentially harmful levels of lead. A Superior Court judge in San Francisco ...

The maker of the popular anti-diarrhea medicine Kaopectate has agreed to reduce levels of toxic lead in its product as part of a settlement with state Attorney General Bill Lockyer. The state sued ...

Environmentalists, consumer groups and state Attorney General Bill Lockyer called the settlement a victory for children, who can suffer brain damage even from low levels of lead. "Hundreds of ...

in a settlement with the state approved Thursday.